Literature DB >> 31845917

Mental Illness and BRCA1/2 Genetic Testing Intention Among Multiethnic Women Undergoing Screening Mammography.

Tarsha Jones1, Katherine Freeman1, Marra Ackerman2, Meghna S Trivedi3, Thomas Silverman4, Peter Shapiro4, Rita Kukafka4, Katherine D Crew4.   

Abstract

OBJECTIVES: To examine associations between patient-reported mental illness diagnosis and symptoms and BRCA1/2 genetic testing intention among women undergoing screening mammography. SAMPLE &
SETTING: 100 multiethnic women of lower socioeconomic status who were undergoing mammography screening and met family history criteria for BRCA1/2 genetic testing. METHODS & VARIABLES: Descriptive and bivariate nonparametric statistics and multivariate logistic regression were used to examine associations between mental illness and genetic testing intention. Variables were anxiety, depression, patient-reported mental illness diagnosis and symptoms, and testing intention.
RESULTS: Prevalence rates of mental illness symptoms were 36% for clinically significant depression and 36% for anxiety. Although 76% of participants intended to undergo genetic testing, only 5% had completed testing. History of mental illness and elevated levels of anxiety and depressive symptoms were positively correlated with testing intention in the bivariate analysis. In multivariate analysis, only younger age and less education were associated with testing intention. IMPLICATIONS FOR NURSING: Future studies should address psychosocial needs and other competing barriers at the patient, provider, and healthcare system levels to increase access to BRCA1/2 genetic testing among multiethnic women.

Entities:  

Keywords:  BRCA1/2; genetic testing; mammography; mental illness; multiethnic women

Mesh:

Substances:

Year:  2020        PMID: 31845917      PMCID: PMC7295180          DOI: 10.1188/20.ONF.E13-E24

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  33 in total

1.  Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Chyke A Doubeni; John W Epling; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

2.  National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.

Authors:  Christopher P Childers; Kimberly K Childers; Melinda Maggard-Gibbons; James Macinko
Journal:  J Clin Oncol       Date:  2017-08-18       Impact factor: 44.544

3.  Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis.

Authors:  David Cibula; Michal Zikan; Ladislav Dusek; Ondrej Majek
Journal:  Expert Rev Anticancer Ther       Date:  2011-08       Impact factor: 4.512

4.  Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Authors:  Jeffrey N Weitzel; Jessica Clague; Arelis Martir-Negron; Raquel Ogaz; Josef Herzog; Charité Ricker; Chelsy Jungbluth; Cheryl Cina; Paul Duncan; Gary Unzeitig; J Salvador Saldivar; Mary Beattie; Nancy Feldman; Sharon Sand; Danielle Port; Deborah I Barragan; Esther M John; Susan L Neuhausen; Garrett P Larson
Journal:  J Clin Oncol       Date:  2012-12-10       Impact factor: 44.544

5.  Population-Based Study of Attitudes toward BRCA Genetic Testing among Orthodox Jewish Women.

Authors:  Eve Y Tang; Meghna S Trivedi; Rita Kukafka; Wendy K Chung; Raven David; Leah Respler; Sarah Leifer; Isaac Schechter; Katherine D Crew
Journal:  Breast J       Date:  2016-11-30       Impact factor: 2.431

6.  Uptake of genetic testing for germline BRCA1/2 pathogenic variants in a predominantly Hispanic population.

Authors:  Julia E McGuinness; Meghna S Trivedi; Thomas Silverman; Awilda Marte; Jennie Mata; Rita Kukafka; Katherine D Crew
Journal:  Cancer Genet       Date:  2019-04-24

7.  Relationships among breast cancer perceived absolute risk, comparative risk, and worries.

Authors:  I M Lipkus; M Kuchibhatla; C M McBride; H B Bosworth; K I Pollak; I C Siegler; B K Rimer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-09       Impact factor: 4.254

8.  Using the Theory of Planned Behavior to Understand Cervical Cancer Screening Among Latinas.

Authors:  Angelica M Roncancio; Kristy K Ward; Ingrid A Sanchez; Miguel A Cano; Theresa L Byrd; Sally W Vernon; Maria Eugenia Fernandez-Esquer; Maria E Fernandez
Journal:  Health Educ Behav       Date:  2015-02-22

9.  Identifying Women at High Risk for Breast Cancer Using Data From the Electronic Health Record Compared With Self-Report.

Authors:  Xinyi Jiang; Julia E McGuinness; Margaret Sin; Thomas Silverman; Rita Kukafka; Katherine D Crew
Journal:  JCO Clin Cancer Inform       Date:  2019-03

10.  Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study.

Authors:  Aurélie Ayme; Valeria Viassolo; Elisabetta Rapiti; Gérald Fioretta; Hyma Schubert; Christine Bouchardy; Pierre O Chappuis; Simone Benhamou
Journal:  Breast Cancer Res Treat       Date:  2014-02-12       Impact factor: 4.872

View more
  3 in total

1.  Anxiety and depression among racial/ethnic minorities and impoverished women testing positive for BRCA1/2 mutations in the United States.

Authors:  Kate E Dibble; Avonne E Connor
Journal:  Support Care Cancer       Date:  2022-03-26       Impact factor: 3.359

2.  Knowledge and perceptions of BRCA1/2 genetic testing and needs of diverse women with a personal or family history of breast cancer in South Florida.

Authors:  Tarsha Jones; Heather Howard; Katherine Freeman-Costin; Ana Creighton; Karen Wisdom-Chambers; Meghan Underhill-Blazey
Journal:  J Community Genet       Date:  2021-02-08

3.  Stress, anxiety, and health-related quality of life in BRCA1/2-positive women with and without cancer: A comparison of four US female samples.

Authors:  Kate E Dibble; Laura K M Donorfio; Preston A Britner; Keith M Bellizzi
Journal:  Gynecol Oncol Rep       Date:  2022-06-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.